Clinical Trials - Tuberculosis
- 
            A5384: A Phase II, Randomized, Open-Label Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents with Tuberculous MeningitisStudy Location: India Eligibility: Target Participant Age 15 years and older Definite, probable, or possible TBM diagnosis from testing performed as part of... Enrollment: Open 
- 
            Identification of Biomarkers That Can Predict Progression from Latent Tuberculosis Infection to Active Tuberculosis DiseaseStudy Location: India Eligibility: Adult, Pediatric, Household contacts Enrollment: Open 
- 
            A5300B/I2003B/PHOENIX, Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis PatientsStudy Location: India Eligibility: Men and women age greater than or equal to 18 year Enrollment: Open 
